The role of glycosphingolipids in SLE T-cell dysfunction

Patients with the autoimmune rheumatic disease SLE are characterized by multiple defects in lymphocyte signaling and function that contribute to disease pathogenesis. Such defects could be attributed to alterations in metabolic processes including abnormal control of lipid biosynthesis pathways. Her...

Full description

Bibliographic Details
Main Author: McDonald, G. L.
Other Authors: Jury, E. C.
Published: University College London (University of London) 2015
Subjects:
610
Online Access:https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.654658
id ndltd-bl.uk-oai-ethos.bl.uk-654658
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-6546582019-01-29T03:17:05ZThe role of glycosphingolipids in SLE T-cell dysfunctionMcDonald, G. L.Jury, E. C.2015Patients with the autoimmune rheumatic disease SLE are characterized by multiple defects in lymphocyte signaling and function that contribute to disease pathogenesis. Such defects could be attributed to alterations in metabolic processes including abnormal control of lipid biosynthesis pathways. Here I reveal that CD4+T cells from SLE patients displayed an altered profile of lipid raft-associated glycosphingolipids (GSLs), in particular lactosylceramide, globotriaosyl (Gb3) and ganglioside GM1, compared to healthy controls. Elevated GSLs in patients were associated with increased expression of liver- X-receptor-beta (LXRβ) a nuclear receptor that controls cellular lipid metabolism and trafficking and influences acquired immune responses. Raised GSL expression was recapitulated in healthy CD4+T cells by in vitro stimulation with synthetic and endogenous LXR agonists, an effect that was blocked by an LXR antagonist. Increased GSL expression in CD4+T cells was associated with intracellular accumulation and accelerated GSL trafficking, reminiscent of cells from patients with glycolipid storage diseases. Inhibiting GSL biosynthesis in vitro using a clinically approved inhibitor (N- butyldeoxynojirimycin) normalized GSL metabolism, corrected CD4+T cell signaling and functional defects and decreased anti-dsDNA antibody production by autologous B cells in SLE patients. Thus I demonstrate a role for defects in lipid metabolism in SLE pathogenesis that could be normalized by targeting GSL biosynthesis. Finally, preliminary findings show that functional T cell subsets have a distinct plasma membrane lipid profile, which is associated with altered expression of molecules associated with lipid metabolism. Furthermore, stimulation of cells with oxysterols has a direct effect on the plasma membrane lipid profile and T cell subset function.610University College London (University of London)https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.654658http://discovery.ucl.ac.uk/1465822/Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 610
spellingShingle 610
McDonald, G. L.
The role of glycosphingolipids in SLE T-cell dysfunction
description Patients with the autoimmune rheumatic disease SLE are characterized by multiple defects in lymphocyte signaling and function that contribute to disease pathogenesis. Such defects could be attributed to alterations in metabolic processes including abnormal control of lipid biosynthesis pathways. Here I reveal that CD4+T cells from SLE patients displayed an altered profile of lipid raft-associated glycosphingolipids (GSLs), in particular lactosylceramide, globotriaosyl (Gb3) and ganglioside GM1, compared to healthy controls. Elevated GSLs in patients were associated with increased expression of liver- X-receptor-beta (LXRβ) a nuclear receptor that controls cellular lipid metabolism and trafficking and influences acquired immune responses. Raised GSL expression was recapitulated in healthy CD4+T cells by in vitro stimulation with synthetic and endogenous LXR agonists, an effect that was blocked by an LXR antagonist. Increased GSL expression in CD4+T cells was associated with intracellular accumulation and accelerated GSL trafficking, reminiscent of cells from patients with glycolipid storage diseases. Inhibiting GSL biosynthesis in vitro using a clinically approved inhibitor (N- butyldeoxynojirimycin) normalized GSL metabolism, corrected CD4+T cell signaling and functional defects and decreased anti-dsDNA antibody production by autologous B cells in SLE patients. Thus I demonstrate a role for defects in lipid metabolism in SLE pathogenesis that could be normalized by targeting GSL biosynthesis. Finally, preliminary findings show that functional T cell subsets have a distinct plasma membrane lipid profile, which is associated with altered expression of molecules associated with lipid metabolism. Furthermore, stimulation of cells with oxysterols has a direct effect on the plasma membrane lipid profile and T cell subset function.
author2 Jury, E. C.
author_facet Jury, E. C.
McDonald, G. L.
author McDonald, G. L.
author_sort McDonald, G. L.
title The role of glycosphingolipids in SLE T-cell dysfunction
title_short The role of glycosphingolipids in SLE T-cell dysfunction
title_full The role of glycosphingolipids in SLE T-cell dysfunction
title_fullStr The role of glycosphingolipids in SLE T-cell dysfunction
title_full_unstemmed The role of glycosphingolipids in SLE T-cell dysfunction
title_sort role of glycosphingolipids in sle t-cell dysfunction
publisher University College London (University of London)
publishDate 2015
url https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.654658
work_keys_str_mv AT mcdonaldgl theroleofglycosphingolipidsinsletcelldysfunction
AT mcdonaldgl roleofglycosphingolipidsinsletcelldysfunction
_version_ 1718968337974689792